Over recent decades, firms have increasingly outsourced research activities to academic institutions, while focusing primarily on product development. For this division of innovative labor to function effectively, the supply of academic research must be responsive to industry demand. To evaluate this responsiveness, we analyze the pharmaceutical industry's reaction to Medicare Part D, a policy shift that substantially increased demand for drugs targeting elderly patients. We find that while firms promptly increased their product development efforts in response to greater market opportunities, academic research output remained virtually unchanged. Notably, firms with internal scientific capabilities eventually expanded their research activities, suggesting that maintaining in-house expertise enabled them to address shortfalls in externally supplied knowledge. These findings highlight the limited responsiveness of academic research to industry demand and underscore the strategic importance of preserving internal scientific capabilities.
This paper examines court selection by plaintiffs in patent litigation. We build a forum shopping model that provides a set of predictions regarding plaintiffs’ court preferences, and the way these preferences depend on the market proximity between the plaintiff and the defendant. Then, using a rich dataset of patent litigation at German regional courts between 2003 and 2008, we estimate the determinants of court selection with alternative-specific conditional logit models. In line with our theoretical predictions, our empirical results show that plaintiffs prefer courts that have shorter proceedings, especially when they compete against the defendants they face. Further, we find negative effects of the plaintiff’s, as well as the defendant’s, distance to court on the plaintiff’s court selection. Our empirical analysis also allows us to infer whether plaintiffs perceive a given court as more or less pro-patentee than another one.